In case you missed it, we shared some big news - www.biomodels.com has a fresh new look! 𝑂𝑢𝑟 𝑛𝑒𝑤 𝑤𝑒𝑏𝑠𝑖𝑡𝑒 𝑖𝑠 𝑛𝑜𝑤 𝑙𝑖𝑣𝑒 𝑎𝑛𝑑 𝑟𝑒𝑎𝑑𝑦 𝑓𝑜𝑟 𝑦𝑜𝑢 𝑡𝑜 𝑑𝑖𝑠𝑐𝑜𝑣𝑒𝑟 ℎ𝑜𝑤 𝑜𝑢𝑟 𝑡𝑎𝑖𝑙𝑜𝑟𝑒𝑑 𝑠𝑒𝑟𝑣𝑖𝑐𝑒𝑠 𝑎𝑛𝑑 𝑒𝑥𝑝𝑎𝑛𝑑𝑖𝑛𝑔 𝑐𝑎𝑝𝑎𝑏𝑖𝑙𝑖𝑡𝑖𝑒𝑠 𝑐𝑎𝑛 𝑠𝑢𝑝𝑝𝑜𝑟𝑡 𝑦𝑜𝑢𝑟 𝑝𝑟𝑒𝑐𝑙𝑖𝑛𝑖𝑐𝑎𝑙 𝑟𝑒𝑠𝑒𝑎𝑟𝑐ℎ 𝑔𝑜𝑎𝑙𝑠 𝑎𝑛𝑑 𝑑𝑟𝑖𝑣𝑒 𝑖𝑛𝑛𝑜𝑣𝑎𝑡𝑖𝑜𝑛. Have questions or want to explore a potential collaboration? Check out our new website and fill out the contact us form to get started! Thank you for being part of the BioModels community!
BioModels’ Post
More Relevant Posts
-
😷Are you ready to redefine the future of drug development? Cytocast is actively seeking Pilot Study Partners to validate our cutting-edge Simulated Cell technology. By leveraging high-performance computing, we can model protein interactions within virtual cells, helping you predict drug effects and potential side effects before clinical trials. Whether you're dealing with a challenging drug candidate, intriguing side effects, or complex drug-drug interactions, our platform provides valuable insights to reduce risks and optimize outcomes. 🚀 Interested in collaborating? Reach out to us at collaboration@cytocast.com and let’s reshape healthcare together! #drugdevelopment #pharmainnovation #clinicaltrials #biotech #cytocast
To view or add a comment, sign in
-
Seeking Investors – Expanding Our Global Footprint At First Choice Bio, we’re tackling one of the biggest challenges in preclinical research—access to reliable, diverse human cell samples. With demand growing 8% annually, shortages and lack of donor diversity are stalling scientific progress. Our solution? A global network of donor collection centers providing fresh, high-quality, and "smart" samples screened for 150+ biomarkers. We are raising a Seed Round of $2.5M to scale our operations and meet the growing demand from researchers. Interested in being part of a biotech solution that bridges the gap between research and clinical success? Let’s connect! 🌐 #biotech #investors #research #innovation #preclinical #diversityinresearch
To view or add a comment, sign in
-
🚀 Exciting news! We’re heading to BioTechX Europe this October. Get ready for two days packed with innovation, as we connect with industry leaders, dive deep into the latest breakthroughs in AI-driven drug discovery, and explore transformative collaborations. 🗓️ When: October 9-10, 2024 📍 Where: Messe Basel, Switzerland This is a golden opportunity to network with inspiring minds, learn cutting-edge trends, and gain insights that will shape the future of pharma and biotech. 💡 We can’t wait to bring back new ideas and partnerships that will fuel the next wave of innovation in pharma. At Entvin, we’re transforming unstructured documents to fuel LLMs and drive innovation in Life Sciences. 🤝 Also, don't miss out on discussing how Entvin can unlock new potential for your pharma research, streamline innovation, and accelerate breakthroughs. Meeting Link: https://lnkd.in/gWVWfpsN See you at BioTechX Europe! #BioTechX #AIInPharma #BioTechXEurope #Innovation #Networking #Pharma #AI
To view or add a comment, sign in
-
Seattle Ranks 10th in Top 10 US Biopharma Clusters https://lnkd.in/gAZmeRex Seattle and the greater Puget Sound rank eighth in NIH funding (2,486 awards totaling $1.842B) and venture capital ($854.5M in 2023 and $334M in Q1–Q2 2024, according to statewide industry group Life Science Washington). The region ranks ninth in lab space (8.5M square feet, according to JLL data cited by Life Science Washington), and 10th in both patents (4,783 families) and jobs – 46,540 according to Life Science Washington’s Economic Impact Report released in April but based on 2022 data. The post Seattle Ranks 10th in Top 10 US Biopharma Clusters appeared first on Life Science Washington . Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
To view or add a comment, sign in
-
𝗦𝘁𝗮𝘆 𝗔𝗵𝗲𝗮𝗱 𝗶𝗻 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗮𝗻𝗱 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝘄𝗶𝘁𝗵 Medvolt Are you passionate about the latest biotech advancements, cutting-edge drug discovery news, and groundbreaking research papers? Look no further! 🌟 𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗶𝗻𝗴 𝗠𝗲𝗱𝘃𝗼𝗹𝘁.𝗮𝗶'𝘀 𝘄𝗲𝗲𝗸𝗹𝘆 𝗻𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿 𝗮𝗻𝗱 𝗯𝗹𝗼𝗴, 𝘆𝗼𝘂𝗿 𝗴𝗼-𝘁𝗼 𝘀𝗼𝘂𝗿𝗰𝗲 𝗳𝗼𝗿: 🔬 The latest biotech news 💊 Innovative drug discovery updates 📚 In-depth research papers 🔍 Exciting biotech-related discoveries 𝗪𝗵𝘆 𝗦𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲? ✅ It's FREE! ✅ Expertly curated content ✅ Stay informed and inspired Join our community of biotech enthusiasts and professionals who are already benefiting from our well-curated insights. Don’t miss out on staying updated with the latest trends and breakthroughs in the biotech, AI, and Drug Discovery world. 👉 Subscribe now: https://lnkd.in/d6Fmfu-N We can't wait to share our research with you 😃... waiting for you to join 😁 Let's advance biotech together! 💡🔍 #Biotech #DrugDiscovery #Research #Newsletter #MedvoltAI #Innovation #SubscribeNow
To view or add a comment, sign in
-
𝗦𝘁𝗮𝘆 𝗔𝗵𝗲𝗮𝗱 𝗶𝗻 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗮𝗻𝗱 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝘄𝗶𝘁𝗵 Medvolt Are you passionate about the latest biotech advancements, cutting-edge drug discovery news, and groundbreaking research papers? Look no further! 🌟 𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗶𝗻𝗴 𝗠𝗲𝗱𝘃𝗼𝗹𝘁.𝗮𝗶'𝘀 𝘄𝗲𝗲𝗸𝗹𝘆 𝗻𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿 𝗮𝗻𝗱 𝗯𝗹𝗼𝗴, 𝘆𝗼𝘂𝗿 𝗴𝗼-𝘁𝗼 𝘀𝗼𝘂𝗿𝗰𝗲 𝗳𝗼𝗿: 🔬 The latest biotech news 💊 Innovative drug discovery updates 📚 In-depth research papers 🔍 Exciting biotech-related discoveries 𝗪𝗵𝘆 𝗦𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲? ✅ It's FREE! ✅ Expertly curated content ✅ Stay informed and inspired Join our community of biotech enthusiasts and professionals who are already benefiting from our well-curated insights. Don’t miss out on staying updated with the latest trends and breakthroughs in the biotech, AI, and Drug Discovery world. 👉 Subscribe now: https://lnkd.in/d6Fmfu-N We can't wait to share our research with you 😃... waiting for you to join 😁 Let's advance biotech together! 💡🔍 #Biotech #DrugDiscovery #Research #Newsletter #MedvoltAI #Innovation #SubscribeNow
To view or add a comment, sign in
-
Where success begins!
Strong partnerships lead to successful preclinical studies! ✅ IBEX knows the importance of quality data while meeting timelines. With our expertise and dedication to our partnerships we will help to meet your research deadlines. Our team is ready to support you in reaching your research objectives with expertise and tailored solutions. Let’s work together to make this year a success! #medicaldevice #preclinicalresearch #Ibexpreclinicalresearch #blessinglives
To view or add a comment, sign in
-
Experience the dynamic fusion of innovation, impact, and professional growth in preclinical research🌟 Discover why this field could be your next big leap forward and let us pave the way to your success: https://buff.ly/3Kyjysy #PreclinicalResearch #Innovation #CareerGrowth
To view or add a comment, sign in
-
🔍 JPMorgan Chase & Co. Healthcare Conference Spotlight Series: #3 - Reinventing R&D Solutions in Biopharma 🌐 📅 Date: Wednesday, January 10 ⏰ Time: 3:20 PM PST 📍 Event: JPM Conference 🔬 Session: Tomorrow’s Lab Delivered Today: Reinventing Research and Development Solutions to Successfully Navigate Today’s Drug Development Landscape 🔬 🚀 In an era where biopharma is rapidly evolving, novel therapies are emerging to tackle complex diseases. The key to harnessing this potential? Scaling and adapting with innovative lab and manufacturing solutions that are both risk-averse and capital-efficient. 💡 Join us for a transformative presentation by Amrit Chaudhuri, CEO of SmartLabs. He will unveil a new paradigm for lab resourcing and infrastructure that's set to revolutionize the industry and expedite scientific research and discovery globally. 🎤 Featured Speaker: 🔹 Amrit Chaudhuri CEO and Co-Founder, SmartLabs A renowned leader and entrepreneur in life sciences, Amrit has a history of fostering R&D innovation and turning discoveries into commercial successes. #JPMConference #Biopharma #Innovation #DrugDevelopment #ResearchAndDevelopment #LifeSciences #SmartLabs #FutureOfScience source:
To view or add a comment, sign in
-
📰 News: 📰 🌟 --Game-Changing Partnership Alert: Innovent and WeComput Team Up for AI-Driven Drug Discovery!-- 🌟 Hey, fellow tech and pharma enthusiasts! We have some thrilling news to share with you. Innovent Biologics and WeComput are joining forces to revolutionize the world of drug discovery and development through AI technology. This partnership is set to pave the way for faster, more efficient drug development, and here’s why you should be excited: 📊 --The Numbers Speak for Themselves:-- 🧪 Innovent aims to cut the R&D cycle time by a significant margin. 💡 Combining WeComput’s molecular design platform, WeMol, with NVIDIA’s BioNeMo adds a powerhouse boost to computational efficiency. 🚀 Innovative drug discovery expected to skyrocket, reducing costs and bringing treatments to patients faster. Dr. Kaijie He and Harry Hu Ge are both pumped about the potential of AI to transform the biopharma sector. With this partnership, we’re looking at a future where groundbreaking treatments are developed at lightning speed. What are your thoughts on the integration of AI in drug discovery? Drop your comments below! Don't forget to follow Bernier Group for the latest updates and insights in the industry. Let’s keep this conversation going! 💬🔬🚀 #AIDriven #Digital #AI #Data #SMB #SME #Strategy #Innovation #Business #ArtificialIntelligence #AnniQ https://lnkd.in/eRsrVWtG
To view or add a comment, sign in
683 followers